ERIC ELDERING,FRANK HERTING,CHRISTIAN KLEIN,MARINUS H.J. VAN OERS
申请号：
US13917327
公开号：
US20140140988A1
申请日:
2013.06.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a MDM2 inhibitor.
